Oxford Finance Corporation and GE Capital Provide $20 Million Senior Credit Facility to NeoVista, Inc.
3/18/2011 7:08:14 AM
More...
|
Oxford Finance Corporation and GE Capital Provide $20 Million Senior Credit Facility to NeoVista, Inc.
3/17/2011 9:52:08 AM
More...
|
NeoVista, Inc.'s Macular Degeneration Device Improves Visual Acuity in Yearlong Study
10/21/2010 7:55:08 AM
More...
|
NeoVista, Inc. Raises $18 Million
3/25/2009 8:20:12 AM
More...
|
FDA Grants NeoVista, Inc.'s Request to Utilize Novel Wet AMD Treatment in Compassionate Case
12/10/2008 12:08:35 PM
More...
|
NeoVista, Inc. Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting Long-Term Phase II Data Continue to Highlight Potential of NeoVista's Epiretinal Brachytherapy
9/29/2008 9:07:54 AM
More...
|
FDA Grants NeoVista, Inc.'s Request to Expand CABERNET Trial to 30 Sites in the U.S.
4/17/2008 10:31:34 AM
More...
|
NeoVista, Inc. Presents One Year Data on Novel Wet AMD Therapy
3/28/2008 11:36:51 AM
More...
|
NeoVista, Inc. First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD Ophthalmic Clinic in Germany First in Europe To Treat Patients With New Focused Radiation Therapy
11/29/2007 8:25:25 AM
More...
|
NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO One-Year Data Provides Ophthalmologists Critical Insight on Novel Beta Radiation Epiretinal Therapy
11/13/2007 7:55:17 AM
More...
|